Presentation Description: Bacterial infections in children being treated for cancer continue to be a significant contributor to treatment related morbidity and mortality. This presentation provided an overview of risk stratification for children with fever and neutropenia and discussed strategies for decision making about empiric antibacterial management. In addition, the data regarding the role of antibacterial prophylaxis in the patients at highest risk for serious bacterial infection were reviewed.
Sarah Alexander, MD
Pediatric Oncologist, SickKids, Toronto, ON
Assistant Professor, Department of Pediatrics
University of Toronto, Toronto, ON